BioNTech SE

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BioNTech SE and other ETFs, options, and stocks.

About BNTX

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators.

CEO

Ugur Sahin

CEOUgur Sahin

Employees

6,772

Employees6,772

Headquarters

Mainz, Rheinland-Pfalz

HeadquartersMainz, Rheinland-Pfalz

Founded

2008

Founded2008

Employees

6,772

Employees6,772

BNTX Key Statistics

Market cap

23.25B

Market cap23.25B

Price-Earnings ratio

-61.08

Price-Earnings ratio-61.08

Dividend yield

—

Dividend yield—

Average volume

1.45M

Average volume1.45M

High today

$102.80

High today$102.80

Low today

$90.12

Low today$90.12

Open price

$101.52

Open price$101.52

Volume

5.15M

Volume5.15M

52 Week high

$131.49

52 Week high$131.49

52 Week low

$81.20

52 Week low$81.20

BNTX News

TipRanks 3d

Positive Outlook for BioNTech SE: Stable Vaccine Business and Growth Catalysts Justify Buy Rating

Analyst Evan Seigerman from BMO Capital maintained a Buy rating on BioNTech SE and keeping the price target at $143.00. Elevate Your Investing Strategy: Take ad...

TipRanks 5d

BioNTech and BMS Reveal Promising Phase 2 Results for Lung Cancer Treatment

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...

Analyst ratings

70%

of 23 ratings

Buy

69.6%

Hold

30.4%

Sell